Francis Patrick Ostronic, Director at Cyclo Therapeutics, Inc. (CYTH), bought 5,000 shares at $4.40 ($22K) on 2021-12-10, disclosed to the SEC on 2021-12-10.
Open-market purchase of $22k CYTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| CYTH | BUY | 2022-05-23 | $10K | — | Filing → |
| CYTH | BUY | 2022-01-24 | $8K | — | Filing → |
| CYTH | BUY | 2022-01-19 | $5K | — | Filing → |